Augmented cytotoxic, mutagenic and genotoxic response triggered by carvedilol and celecoxib combinations. Brazilian Journal of Pharmaceutical Sciences, [S. l.], v. 54, n. 1, p. e17292, 2018. DOI: 10.1590/s2175-97902018000117292. Disponível em: https://revistas.usp.br/bjps/article/view/146838.. Acesso em: 5 may. 2024.